daniela cilloni

PROFESSOR

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Daniela Cilloni is a faculty member at the University of Turin, Italy. Her research primarily focuses on hematological malignancies, including myelodysplastic neoplasms, chronic myeloid leukemia, and acute myeloid leukemia. She has contributed to the understanding of treatment impacts on patients' quality of life and the molecular mechanisms underlying various blood cancers. Her recent publications examine novel therapeutic approaches and diagnostic methodologies in the field of leukemia and thrombosis.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (20)

Barbara Pergolizzi

University of Turin

ITALY

daniela cilloni

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers

Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells

Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach

Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and Why

The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid Tumors

Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review

A Radiation-Free Approach Based on the Whole-Body MRI Has Shown a High Level of Accuracy in the Follow-Up of Lymphoma Patients—A Single Center Retrospective Study

A Leukemic Target with a Thousand Faces: The Mitochondria

Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey

mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

<i>SF3B1</i> Mutations in Hematological Malignancies

Detection of <i>SF3B1</i> p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms

HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis

The Downregulation of Both Giant HERCs, <i>HERC1</i> and <i>HERC2</i>, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation

Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells

Droplet Digital PCR for <i>BCR–ABL1</i> Monitoring in Diagnostic Routine: Ready to Start?

Collaborators (20)

Barbara Pergolizzi

Chiara Riganti

Elisabetta Abruzzese

MARCO LO IACONO

Riccardo Haupt

MARIA TERESA BOCHICCHIO

Antonio Cuneo

Daniele Calistri

Muhammad Shahzad Ali

Massimiliano BONIFACIO

Enrico Berrino

Giuseppe Alberto Maria PALUMBO

Florian Heidel

Serena Stanga

Monica Muraca

Joanna Kopecka

Maria Teresa VOSO

Enrico Bracco

Giovanni Caocci

Ymera Pignochino

Make your next move.